Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Stereotactic Body Radiation Therapy 1 Ovarian Neoplasms 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Brain Neoplasms 1

Interventions

anlotinib 1 Angiogenesis Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stereotactic Body Radiation Therapy × Angiogenesis Inhibitors × Clear all

NCT04912128 2021-06-03

AnloSBRT

Peking University Third Hospital

Stereotactic Body Radiation Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡